NKTX Nkarta, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 10, 2026
$2,58
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,70minimo 52 sett.
$3,72massimo 52 sett.
Capitalizzazione di Mercato
$183M
P/E
-1.8
EPS
$-1.41
Ricavi
$0
i tuoi badge
Intervallo 52 sett.
$2–$4
Rating Analisti
BUY
Prezzo Obiettivo
$11
P/E
-1.8
ROE
-31.1%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
NKTX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$2.58
Capitalizzazione di Mercato
$183M
P/E
-1.8
EPS
$-1.41
Ricavi
$0
ROE
-31.1%
Intervallo 52 sett.
$2–$4
NKTX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$02019-12-31 → 2025-12-31
EPS$-1.412021-12-31 → 2025-12-31
Flusso di cassa libero$-90M2020-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | NKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -1.8media 5 anni ≈-2.8 | ≈-2.8 | · | · | |
| P/B | 0.6media 5 anni ≈1.0 | ≈1.0 | 3.6 | Sottovalutato | |
| Price / FCF (Prezzo / FCF) | -2.0media 5 anni ≈-3.1 | ≈-3.1 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -2.1media 5 anni ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.6media 5 anni ≈1.0 | ≈1.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | NKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -23.0%media 5 anni ≈-26.8% | ≈-26.8% | -31.6% | Di prim'ordine | |
| ROE | -31.1%media 5 anni ≈-32.2% | ≈-32.2% | -70.9% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | NKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 8.0media 5 anni ≈14.7 | ≈14.7 | 7.9 | In linea | |
| Quick Ratio | 12.4media 5 anni ≈14.3 | ≈14.3 | 6.3 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | NKTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.1 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$0.00 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-1.1%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 10, 2026 | $-0.54 | $-0.38 | -40.8% |
| 31 Marzo 2026 | Mag 12, 2026 | $-0.37 | $-0.38 | 2.6% |
| 31 Dicembre 2025 | $-0.37 | $-0.32 | -14.1% | |
| 30 Settembre 2025 | $-0.29 | $-0.32 | 9.3% | |
| 30 Giugno 2025 | $-0.31 | $-0.36 | 14.4% | |
| 31 Marzo 2025 | $-0.43 | $-0.45 | 4.2% | |
| 31 Dicembre 2024 | $-0.35 | $-0.42 | 16.9% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | $0 | · | $115.0K | |
| R&D Expense | $90M | $97M | $97M | $91M | $63M | $36M | $17M | |
| SG&A Expense | $32M | $31M | $35M | $28M | $23M | $15M | $5M | |
| Operating Expenses | $122M | $128M | $132M | $119M | $86M | $52M | $22M | |
| Operating Income | $-122M | $-128M | $-132M | $-119M | $-86M | $-52M | $-22M | |
| Other Non-op | $2M | $87.0K | $42.0K | $-470.0K | $-16.0K | $-3.0K | $18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | $-21M | |
| EPS (Basic) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| EPS (Diluted) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| Shares (Basic) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| Shares (Diluted) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| EBITDA | $-113M | $-119M | $-126M | $-116M | $-85M | $-51M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $28M | $31M | $37M | $61M | $97M | $21M | |
| Short-term Investments | $237M | $239M | $217M | $315M | $177M | $218M | $16M | |
| Prepaid Expense | $6M | $6M | $5M | $9M | $8M | $4M | $474.0K | |
| Other Current Assets | $2M | $3M | $2M | $3M | $3M | $1M | $67.0K | |
| Current Assets | $283M | $273M | $253M | $361M | $246M | $319M | $37M | |
| PP&E (Net) | $67M | $75M | $79M | $62M | $13M | $9M | $3M | |
| PP&E (Gross) | $96M | $96M | $91M | $68M | $16M | $11M | $4M | |
| Accum. Depreciation | $29M | $21M | $12M | $6M | $3M | $1M | $645.0K | |
| Other Non-current Assets | $2M | $4M | $4M | $2M | $1M | $547.0K | $455.0K | |
| Total Assets | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Accounts Payable | $2M | $638.0K | $4M | $2M | $1M | $1M | $2M | |
| Accrued Liabilities | $13M | $12M | $14M | $16M | $9M | $6M | $3M | |
| Current Liabilities | $22M | $19M | $23M | $22M | $13M | $9M | $8M | |
| Capital Leases | $70M | $74M | $82M | $79M | $10M | $8M | $6M | |
| Other Non-current Liabilities | $87.0K | $87.0K | · | · | $18.0K | $82.0K | $134.0K | |
| Total Liabilities | $92M | $93M | $106M | $101M | $23M | $16M | $14M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-648M | $-544M | $-435M | $-318M | $-204M | $-118M | $-27M | |
| AOCI | $407.0K | $674.0K | $8.0K | $-679.0K | $-150.0K | $3.0K | $-2.0K | |
| Stockholders' Equity | $312M | $408M | $273M | $372M | $251M | $321M | $-25M | |
| Liabilities + Equity | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Shares Outstanding | 71,078,531 | 70,645,139 | 49,181,295 | 48,877,806 | 32,971,107 | 32,627,963 | 1,600,601 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $9M | $6M | $3M | $2M | $800.0K | $400.0K | |
| Stock-based Comp | $9M | $17M | $17M | $17M | $14M | $7M | $947.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-2M | $-17M | $8M | $37M | $2M | $40M | · | |
| Operating Cash Flow | $-89M | $-100M | $-86M | $-57M | $-68M | $-44M | $-18M | |
| CapEx | $1M | $4M | $28M | $47M | $5M | $8M | $2M | |
| Investing Cash Flow | $100M | $-130M | $79M | $-185M | $33M | $-210M | $-18M | |
| Financing Cash Flow | $141.0K | $226M | $691.0K | $219M | $1M | $330M | $50M | |
| Net Change in Cash | $12M | $-3M | $-6M | $-23M | $-34M | $76M | $13M | |
| Free Cash Flow | $-90M | $-104M | $-114M | $-104M | $-73M | $-51M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -23.0% | -24.7% | -27.6% | -30.5% | -28.1% | -47.3% | · | |
| ROE | -31.1% | -25.9% | -41.2% | -29.5% | -33.0% | -27.9% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 | 36.1 | · | |
| Quick Ratio | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 | 35.7 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.39 | $5.78 | $5.56 | $7.62 | $7.61 | $9.84 | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | |
| Cash Flow / Share | $-1.20 | $-1.47 | $-1.76 | $-1.31 | · | · | · | |
| Cash / Share | $0.56 | $0.39 | $0.63 | $0.77 | $1.84 | $2.96 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | |
| EPS (TTM) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | · | $0 | · | · | |
| Net Income TTM | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | · | |
| Market Cap | $131M | $176M | $325M | $293M | $506M | $2.01B | · | |
| P/E | -1.3 | -1.6 | -2.8 | -2.3 | -5.9 | · | · | |
| P/B | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Tangible Book | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Cash Flow | -1.5 | -1.8 | -3.8 | -5.1 | -7.5 | -46.1 | · | |
| P / FCF | -1.5 | -1.7 | -2.8 | -2.8 | -6.9 | -39.3 | · | |
| Earnings Yield | -76.2% | -64.3% | -36.4% | -43.6% | -17.1% | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $25M | $25M | $20M | $21M | $24M | $23M | $25M | $23M | $25M | $23M | $22M | $25M | $26M | $27M | $23M | |
| SG&A Expense | $14M | $6M | $6M | $7M | $6M | $12M | $8M | $9M | $8M | $8M | $8M | $7M | $12M | $8M | $8M | $7M | |
| Operating Expenses | $43M | $31M | $31M | $27M | $27M | $37M | $31M | $34M | $31M | $33M | $31M | $29M | $37M | $34M | $35M | $30M | |
| Operating Income | $-43M | $-31M | $-31M | $-27M | $-27M | $-37M | $-31M | $-34M | $-31M | $-33M | $-31M | $-29M | $-37M | $-34M | $-35M | $-30M | |
| Other Non-op | $222.0K | $206.0K | $256.0K | $2M | $239.0K | $205.0K | $94.0K | $-3.0K | $-2.0K | $-2.0K | $-25.0K | $33.0K | $1.0K | $33.0K | $-489.0K | $17.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-28M | $-27M | $-22M | $-23M | $-32M | $-26M | $-28M | $-25M | $-30M | $-28M | $-26M | $-33M | $-31M | $-33M | $-28M | |
| EPS (Basic) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| EPS (Diluted) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| Shares (Basic) | 74,494,855 | 74,257,973 | · | 74,024,543 | 73,977,625 | 73,916,477 | · | 73,563,316 | 73,494,523 | 50,682,469 | · | 49,062,799 | 48,970,391 | 48,921,326 | · | 48,630,328 | |
| Shares (Diluted) | 74,494,855 | 74,257,973 | · | 74,024,543 | 73,977,625 | 73,916,477 | · | 73,563,316 | 73,494,523 | 50,682,469 | · | 49,062,799 | 48,970,391 | 48,921,326 | · | 48,630,328 | |
| EBITDA | $-40M | $-29M | · | $-25M | $-25M | $-34M | · | $-31M | $-28M | $-30M | · | $-27M | $-36M | $-34M | · | $-30M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $27M | $40M | $60M | $53M | $53M | $28M | $57M | $120M | $250M | $31M | $38M | $29M | $54M | $37M | $40M | |
| Short-term Investments | $158M | $203M | $237M | $222M | $236M | $213M | $239M | $226M | $204M | $187M | $217M | $237M | $252M | $270M | $315M | $353M | |
| Prepaid Expense | $5M | $5M | $6M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $6M | $6M | $9M | $9M | $9M | |
| Other Current Assets | · | · | $2M | · | · | · | $3M | · | · | · | $2M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $188M | $236M | $283M | $289M | $297M | $272M | $273M | $290M | $332M | $443M | $253M | $281M | $287M | $332M | $361M | $401M | |
| PP&E (Net) | $57M | $64M | $67M | $68M | $70M | $73M | $75M | $76M | $78M | $79M | $79M | $78M | $76M | $70M | $62M | $30M | |
| PP&E (Gross) | $93M | $96M | $96M | $96M | $96M | $96M | $96M | $95M | $94M | $92M | $91M | $87M | $84M | $76M | $68M | $35M | |
| Accum. Depreciation | $36M | $31M | $29M | $28M | $25M | $23M | $21M | $19M | $16M | $14M | $12M | $9M | $7M | $7M | $6M | $5M | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $2M | |
| Total Assets | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Accounts Payable | $4M | $2M | $2M | $1M | $2M | $1M | $638.0K | $2M | $4M | $3M | $4M | $4M | $3M | $5M | $2M | $9M | |
| Accrued Liabilities | $12M | $10M | $13M | $11M | $11M | $11M | $12M | $14M | $12M | $13M | $14M | $15M | $18M | $15M | $16M | $12M | |
| Current Liabilities | $24M | $18M | $22M | $19M | $19M | $19M | $19M | $22M | $21M | $22M | $23M | $26M | $27M | $26M | $22M | $26M | |
| Capital Leases | $66M | $68M | $70M | $70M | $72M | $73M | $74M | $79M | $80M | $81M | $82M | $83M | $84M | $86M | $79M | $78M | |
| Other Non-current Liabilities | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | · | · | · | · | · | · | · | · | $5.0K | |
| Total Liabilities | $90M | $86M | $92M | $89M | $91M | $92M | $93M | $101M | $101M | $103M | $106M | $109M | $111M | $112M | $101M | $105M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-717M | $-676M | $-648M | $-621M | $-599M | $-576M | $-544M | $-518M | $-490M | $-465M | $-435M | $-408M | $-382M | $-349M | $-318M | $-285M | |
| AOCI | $-425.0K | $-130.0K | $407.0K | $536.0K | $362.0K | $652.0K | $674.0K | $2M | $-263.0K | $-127.0K | $8.0K | $-409.0K | $-601.0K | $-174.0K | $-679.0K | $-1M | |
| Stockholders' Equity | $248M | $286M | $312M | $338M | $358M | $379M | $408M | $431M | $453M | $474M | $273M | $297M | $318M | $347M | $372M | $399M | |
| Liabilities + Equity | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Shares Outstanding | · | · | 71,078,531 | · | · | · | 70,645,139 | · | · | · | 49,181,295 | · | · | · | 48,877,806 | · |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $800.0K | $700.0K | $700.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | |
| Restructuring | · | · | $-59.0K | $-26.0K | $-86.0K | $5M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-24M | $-28M | $-22M | $-19M | $-19M | $-30M | $-25M | $-25M | $-22M | $-29M | $-23M | $-20M | $-22M | $-21M | $-7M | $-15M | |
| CapEx | $183.0K | $413.0K | $560.0K | $-8.0K | $138.0K | $518.0K | $1M | $777.0K | $2M | $175.0K | $7M | $6M | $10M | $5M | $35M | $8M | |
| Investing Cash Flow | $21M | $16M | $1M | $25M | $19M | $54M | $-5M | $-39M | $-108M | $21M | $16M | $29M | $-3M | $37M | $5M | $-79M | |
| Financing Cash Flow | $676.0K | $6.0K | $64.0K | $0 | $77.0K | $0 | $184.0K | $2.0K | $-368.0K | $226M | $295.0K | $0 | $395.0K | $1.0K | $424.0K | $3M | |
| Net Change in Cash | $-2M | $-12M | $-20M | $7M | $816.0K | $25M | $-29M | $-63M | $-130M | $219M | $-7M | $9M | $-25M | $16M | $-2M | $-91M | |
| Free Cash Flow | · | $-29M | · | · | · | $-30M | · | · | · | $-29M | · | · | · | $-26M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.3% | -6.6% | · | -4.5% | -4.6% | -6.1% | · | -6.0% | -5.1% | -5.7% | · | -5.6% | -7.1% | -8.1% | · | -7.1% | |
| ROE | -13.3% | -8.4% | · | -5.7% | -5.7% | -7.5% | · | -7.8% | -6.5% | -7.2% | · | -7.4% | -9.0% | -10.7% | · | -8.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 13.0 | · | 15.2 | 15.7 | 14.5 | · | 12.9 | 15.9 | 20.0 | · | 11.0 | 10.8 | 12.8 | · | 15.2 | |
| Quick Ratio | 7.8 | 12.7 | · | 14.9 | 15.3 | 14.2 | · | 12.6 | 15.6 | 19.7 | · | 10.7 | 10.5 | 12.4 | · | 14.8 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.40 | · | · | · | $-0.56 | · | · | · | $-0.42 | · | · | |
| EPS (TTM) | $-1.58 | $-1.35 | · | $-1.32 | $-1.42 | $-1.45 | · | $-1.88 | $-2.01 | $-2.35 | · | $-2.46 | $-2.52 | $-2.45 | · | · |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-117M | $-100M | · | $-103M | $-109M | $-111M | · | $-111M | $-108M | $-116M | · | $-122M | $-125M | $-119M | · | · | |
| P/E | -1.8 | -1.6 | · | -1.6 | -1.2 | -1.3 | · | -2.4 | -2.9 | -4.6 | · | -0.6 | -0.9 | -1.4 | · | · | |
| Earnings Yield | -55.8% | -64.0% | · | -63.8% | -85.5% | -78.8% | · | -41.6% | -34.0% | -21.7% | · | -177.0% | -115.1% | -69.0% | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $0 | $0 | · | · | $0 |
| Utile netto | $-104M | $-109M | $-118M | $-114M | $-86M |
| EPS Diluito | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 |
| Quick Ratio | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-90M | $-104M | $-114M | $-104M | $-73M |
Proprietari istituzionali (13F) 146 filer · $167.8M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
146
Valore detenuto
$167.8M
Nuove posizioni
27
Posizioni chiuse
13
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 27 (+5 vs trimestre precedente) | 13 (+4 vs trimestre precedente) | 51 (+4 vs trimestre precedente) | 37 (+6 vs trimestre precedente) | +230K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $30.578.515 | 10.805.129 | 18,23% | Azioni |
| BlackRock, Inc. | $17.829.600 | 6.300.212 | 10,63% | Azioni |
| NEA Management Company, LLC | $10.099.650 | 3.568.781 | 6,02% | Azioni |
| SAMSARA BIOCAPITAL, LLC | $9.926.695 | 3.507.666 | 5,92% | Azioni |
| SR One Capital Management, LP | $9.433.332 | 3.333.333 | 5,62% | Azioni |
| GSK plc | $8.916.572 | 3.150.732 | 5,32% | Azioni |
| Monaco Asset Management SAM | $6.716.722 | 2.373.400 | 4,00% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.300.754 | 2.226.415 | 3,76% | Azioni |
| CITADEL ADVISORS LLC | $6.154.528 | 2.174.745 | 3,67% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $5.301.419 | 1.873.293 | 3,16% | Azioni |
| VANGUARD GROUP INC | $4.805.134 | 2.597.370 | 2,86% | Azioni |
| STATE STREET CORP | $3.639.688 | 1.286.109 | 2,17% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $3.638.743 | 1.285.507 | 2,17% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $3.332.755 | 1.177.652 | 1,99% | Azioni |
| WASATCH ADVISORS LP | $3.329.257 | 1.577.847 | 1,98% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $2.983.530 | 1.054.251 | 1,78% | Azioni |
| AWM Investment Company, Inc. | $2.563.980 | 906.000 | 1,53% | Azioni |
| Blackstone Inc. | $2.114.135 | 747.044 | 1,26% | Azioni |
| MARSHALL WACE, LLP | $1.904.620 | 673.010 | 1,14% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $1.650.595 | 583.249 | 0,98% | Azioni |
| JPMORGAN CHASE & CO | $1.604.493 | 562.980 | 0,96% | Azioni |
| Peapod Lane Capital LLC | $1.556.282 | 549.923 | 0,93% | Azioni |
| Alyeska Investment Group, L.P. | $1.372.097 | 484.840 | 0,82% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $1.367.703 | 483.211 | 0,82% | Azioni |
| Nuveen, LLC | $1.328.840 | 469.555 | 0,79% | Azioni |
| GOLDMAN SACHS GROUP INC | $1.228.169 | 433.982 | 0,73% | Azioni |
| TWO SIGMA ADVISERS, LP | $1.197.320 | 647.200 | 0,71% | Azioni |
| NORTHERN TRUST CORP | $1.051.133 | 371.425 | 0,63% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $985.366 | 348.186 | 0,59% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $915.955 | 323.659 | 0,55% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $854.422 | 301.916 | 0,51% | Azioni |
| XTX Topco Ltd | $820.658 | 289.985 | 0,49% | Azioni |
| MORGAN STANLEY | $746.479 | 263.773 | 0,44% | Azioni |
| Invesco Ltd. | $586.701 | 207.315 | 0,35% | Azioni |
| IEQ CAPITAL, LLC | $501.017 | 177.038 | 0,30% | Azioni |
| D. E. Shaw & Co., Inc. | $459.900 | 162.509 | 0,27% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $370.659 | 130.975 | 0,22% | Azioni |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $367.900 | 130.000 | 0,22% | Azioni |
| FMR LLC | $367.736 | 129.942 | 0,22% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $357.539 | 126.339 | 0,21% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347.524 | 122.800 | 0,21% | Azioni |
| BARCLAYS PLC | $344.042 | 121.570 | 0,21% | Azioni |
| Qube Research & Technologies Ltd | $341.889 | 120.809 | 0,20% | Azioni |
| MACKENZIE FINANCIAL CORP | $325.985 | 115.189 | 0,19% | Azioni |
| Bank of New York Mellon Corp | $324.978 | 114.833 | 0,19% | Azioni |
| JANE STREET GROUP, LLC | $315.899 | 111.625 | 0,19% | Azioni |
| Point72 Asset Management, L.P. | $302.261 | 106.806 | 0,18% | Azioni |
| Man Group plc | $283.133 | 100.047 | 0,17% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $268.428 | 94.851 | 0,16% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $233.922 | 82.658 | 0,14% | Azioni |
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×4 depositi | 19 Maggio 2026 | 4,90% | Modifica | Investimento passivo | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Srinivas Akkaraju ×4 depositi | 24 Novembre 2025 | 4,90% | Modifica | · | SEC |
| LSP 6 Management B.V., LSP 6 Holding C.V., LSP 6 NK Holding B.V ×3 depositi | 12 Febbraio 2025 | 4,00% | Modifica | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×3 depositi | 29 Marzo 2024 | · | Deposito iniziale | · | SEC |
| Novo Holdings A/S ×4 depositi | 03 Giugno 2022 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 28 insider · 10 dirigenti · 11 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul J Hastings | Chief Executive Officer | 18 Giugno 2026 S | 390.247 | 0 | 2 | $-58.728 |
| Matthew Plunkett | Chief Financial Officer | 09 Luglio 2020 A | · | 0 | 0 | $0 |
| Nadir Mahmood | President | 15 Gennaio 2026 S | 167.727 | 0 | 1 | $-11.693 |
| Shawn Marshall Rose | Chief Medical Officer, Head of Research & Development | 06 Gennaio 2026 A | 70.000 | 0 | 0 | $0 |
| Alyssa Levin | Chief Financial and Business Officer | 15 Gennaio 2025 S | 102.662 | 0 | 0 | $0 |
| David Shook | Chief Medical Officer, Head of Research & Development | 15 Gennaio 2025 S | 190.955 | 0 | 0 | $0 |
| Ralph Brandenberger | Chief Technical Officer | 15 Gennaio 2025 S | 124.796 | 0 | 0 | $0 |
| Alicia J. Hager | Chief Legal Officer | 15 Gennaio 2025 S | 146.735 | 0 | 0 | $0 |
| James Trager | Chief Scientific Officer | 18 Giugno 2024 S | 150.959 | 0 | 0 | $0 |
| Kanya Rajangam | Chief Medical Officer | 14 Gennaio 2022 A | 12.800 | 0 | 0 | $0 |
| George Vratsanos | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Zachary Scheiner | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Angela Thedinga | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Ali Behbahani | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Michael Dybbs | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Simeon George | Direttore | 10 Giugno 2026 A | 451.659 | 0 | 0 | $0 |
| Leone D Patterson | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Fouad Oscar Azzam | Direttore | 07 Giugno 2023 A | · | 0 | 0 | $0 |
| Tiba Aynechi | Direttore | 08 Giugno 2022 A | · | 0 | 0 | $0 |
| Laura Shawver | Direttore | 08 Giugno 2022 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | Proprietario del 10% | 14 Luglio 2020 C | 2.902.115 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Proprietario del 10% | 14 Luglio 2020 C | 2.902.115 | 0 | 0 | $0 |
| Peter W. Sonsini | Proprietario del 10% | 14 Luglio 2020 C | 2.902.115 | 0 | 0 | $0 |
| Novo Holdings A/S | Proprietario del 10% | 14 Luglio 2020 C | 2.793.865 | 0 | 0 | $0 |
| Forest Baskett | Proprietario del 10% | 14 Luglio 2020 C | 2.902.115 | 0 | 0 | $0 |
| Scott D. Sandell | Proprietario del 10% | 14 Luglio 2020 C | 2.902.115 | 0 | 0 | $0 |
| Joshua Makower | Proprietario del 10% | 14 Luglio 2020 C | 2.902.115 | 0 | 0 | $0 |
| GSK plc | · | 14 Luglio 2020 A | 3.150.732 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 17 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 80.111 SH | 01 Ottobre 2026 | Giornaliero |
| IWC · iShares Trust | 0,03% | 149.326 SH | 11 Settembre 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 38.962 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 103.233 SH | 30 Settembre 2026 | Giornaliero |
| IWM · iShares Trust | 0,00% | 1.123.160 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 21.336 NS | 31 Luglio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 145.492 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 3.413 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.031 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17.065 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 8.973 SH | 03 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 599.527 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.567.021 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 259.168 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.786 SH | 19 Agosto 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 6.442 NS | 31 Luglio 2026 | N-PORT |
| IWN · iShares Trust | · | 452.090 SH | 11 Settembre 2026 | Giornaliero |
NKTX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 13 analisti
COMPRA
Target mediano
$10.50
+307,8%
4 30,8%
Acquisto forte
8 61,5%
Compra
1 7,7%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
6 analisti · 2026-10-03Target medio $10.83 +320,7%
← Sotto tutti i target
Prezzo attuale $2.58
Basso$9.00
Media$10.83
Alto$14.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 10, 2026